Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, September 24, 2018
ZappRx announced its partnership with Dunn Meadow, a national specialty pharmacy, headquartered in New Jersey.
read more
Monday, September 24, 2018
McKesson Medical-Surgical has signed an exclusive agreement with ILÚM Health Solutions that provides innovative technology and services to support infectious disease management, to serve the U.S. community hospital market.
read more
Tuesday, September 25, 2018
AGC will be establishing a cGMP-compatible mammalian cell culture facility at its Chiba Plant designed to take on contracts for antibody biopharmaceutical development and production
read more
Tuesday, September 25, 2018
Cambrex announced that it is to establish a center of excellence for API clinical supply and process development at its site in High Point, North Carolina.
read more
Tuesday, September 25, 2018
Cantrell Drug Company, a 503B Registered Outsourcing Facility, announced that the company has received final approval from the FDA to begin producing and shipping product.
read more
Tuesday, September 25, 2018
Elpro has announced the release of its new temperature monitoring device, the LIBERO ITS.
read more
Tuesday, September 25, 2018
Anaeropharma announced Astellas have signed a collaborative research agreement concerning the creation of novel anti-tumor drugs that utilizes characteristic features of Bifidobacterium longum.
read more
Wednesday, September 26, 2018
WuXi Biologics and I-Mab Biopharma jointly announced that I-Mab has expanded strategic collaboration with WuXi Biologics and licensed proprietary WuXiBody Platform to develop three bispecific antibodies.
read more
Wednesday, September 26, 2018
GB Sciences has selected Catalent to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of proprietary APIs for its Parkinson’s disease therapies
read more
Wednesday, September 26, 2018
Experic announced that Justin Lacombe, Ph.D. has joined its leadership team as Director of Pharmaceutical Development and Manufacturing Services.
read more
Wednesday, September 26, 2018
Selexis SA and Hoba Therapeutics announced they have entered into an agreement to advance the development of Hoba’s clinical candidate HB-086 for peripheral neuropathic pain.
read more
Wednesday, September 26, 2018
As we all know, compounding can play an important role in patient care, but because compounded drug products are not reviewed by FDA for safety, effectiveness, or quality before they are marketed, they should be used only when necessary to meet ...
read more
Thursday, September 27, 2018
Brammer Bio announces that a three-year, $200 million investment program is on track to establish over 30 suites for clinical and commercial viral vector supply for a broad pipeline of advanced gene therapies and gene-modified cell therapies.
read more
Thursday, September 27, 2018
Diplomat Pharmacy has opened a 75,000-square-foot facility in Chandler, Arizona, to bolster pharmacy operations and ensure business continuity.
read more
Thursday, September 27, 2018
ABL announces the hire of Jarlath Keating as Chief Commercial Officer (CCO).
read more